1
|
Widhe B and Widhe T: Initial symptoms and
clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint
Surg Am. 82:667–674. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lin JS, Chen R, Yan W and Chen DD:
Enhancing soft-tissue reattachment with artificial mesh in joint
endoprosthetic reconstruction for bone tumors. Zhonghua Zhong Liu
Za Zhi. 39:540–544. 2017.(In Chinese). PubMed/NCBI
|
3
|
Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ,
Liao M and Chen JX: Saikosaponin a and its epimer saikosaponin d
exhibit anti-inflammatory activity by suppressing activation of
NF-κB signaling pathway. Int Immunopharmacol. 14:121–126. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Wong VK, Zhang MM, Zhou H, Lam KY, Chan
PL, Law CK, Yue PY and Liu L: Saikosaponin-d enhances the
anticancer potency of TNF-α via overcoming its undesirable response
of activating NF-Kappa B signalling in cancer cells. Evid Based
Complement Alternat Med. 2013:7452952013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Tundis R, Bonesi M, Deguin B, Loizzo MR
and Menichini F, Conforti F, Tillequin F and Menichini F: Cytotoxic
activity and inhibitory effect on nitric oxide production of
triterpene saponins from the roots of Physospermum verticillatum
(Waldst & Kit) (Apiaceae). Bioorg Med Chem. 17:4542–4547. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hsu YL, Kuo PL and Lin CC: The
proliferative inhibition and apoptotic mechanism of Saikosaponin D
in human non-small cell lung cancer A549 cells. Life Sci.
75:1231–1242. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Hsu YL, Kuo PL, Chiang LC and Lin CC:
Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in
induction of apoptosis and cell cycle arrest by saikosaponin d in
human hepatoma cell lines. Cancer Lett. 213:213–221. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Motoo Y and Sawabu N: Antitumor effects of
saikosaponins, baicalin and baicalein on human hepatoma cell lines.
Cancer Lett. 86:91–95. 1994. View Article : Google Scholar : PubMed/NCBI
|
9
|
Tsuyoshi H, Wong VKW, Han Y, Orisaka M,
Yoshida Y and Tsang BK: Saikosaponin-d, a calcium mobilizing agent,
sensitizes chemoresistant ovarian cancer cells to cisplatin-induced
apoptosis by facilitating mitochondrial fission and G2/M arrest.
Oncotarget. 8:99825–99840. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhuang Y, Gan Y and Tang T: Saikosaponin-d
promotes apoptosis of osteosarcoma cells. International Journal of
Orthopaedics. 38:115–120. 2017.
|
11
|
Zhang P, Wang X and Guo X: Saikosaponin-D
inhibits migration and invasion of osteosarcoma cell line MG-63 by
reversing EMT. J Modern Oncol. 25:2561–2564. 2017.
|
12
|
Yang C, Fan W, Ou X and Yuan B: Inhibitory
effect of Saikosaponin D on proliferation of osteosarcoma 143B
cells. Chin Pharm. 1:9–13. 2018.
|
13
|
Wong VK, Li T, Law BY, Ma ED, Yip NC,
Michelangeli F, Law CK, Zhang MM, Lam KY, Chan PL and Liu L:
Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell
death in apoptosis-defective cells. Cell Death Dis. 4:e7202013.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Fan Y, Zhan Q, Xu H, Li L, Li C, Xiao Q,
Xiang S, Hui T, Xiang T and Ren G: Epigenetic identification of
ZNF545 as a functional tumor suppressor in multiple myeloma via
activation of p53 signaling pathway. Biochem Biophys Res Commun.
474:660–666. 2016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Xiong J, Liu Y, Jiang L, Zeng Y and Tang
W: High expression of long non-coding RNA lncRNA-ATB is correlated
with metastases and promotes cell migration and invasion in renal
cell carcinoma. Jpn J Clin Oncol. 46:378–384. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wu X, Zhang P, Zhu H, Li S, Chen X and Shi
L: Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of
gastric cancer and promotes tumorigenesis via activation of Wnt
signaling pathway. Biomed Pharmacother. 96:1103–1108. 2017.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhao L, Zhang H, Bao J, Liu J and Ji Z:
Saikosaponin-d protects renal tubular epithelial cell against high
glucose induced injury through modulation of SIRT3. Int J Clin Exp
Med. 8:6472–6481. 2015.PubMed/NCBI
|
18
|
Cao W, Peng T and Zhou Y: Long noncoding
RNA activated by transforming growth factor-β promotes cancer
development and is a prognostic marker in cervical cancer. J Cancer
Res Ther. 13:801–806. 2017. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gou X, Zhao X and Wang Z: Long noncoding
RNA PVT1 promotes hepatocellular carcinoma progression through
regulating miR-214. Cancer Biomark. 20:511–519. 2017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Xu Y, Hu J, Zhang C and Liu Y:
MicroRNA-320 targets mitogen-activated protein kinase 1 to inhibit
cell proliferation and invasion in epithelial ovarian cancer. Mol
Med Rep. 16:8530–8536. 2017. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
He SX, Luo JY, Zhao G, Xu JL, Wang YL, Fu
H and Dong L: Effect of saikosaponins-d on cyclooxygenase-2
expression of human hepatocellular carcinoma cell line SMMC-7721.
Zhonghua Gan Zang Bing Za Zhi. 14:712–714. 2016.(In Chinese).
|
24
|
Tu Y: The discovery of artemisinin
(qinghaosu) and gifts from Chinese medicine. Nat Med. 17:1217–1220.
2011. View
Article : Google Scholar : PubMed/NCBI
|
25
|
Girdhani S, Bhosle SM, Thulsidas SA, Kumar
A and Mishra KP: Potential of radiosensitizing agents in cancer
chemo-radiotherapy. J Cancer Res Ther. 1:129–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Song W and Zhu YW: Chinese medicines in
diabetic retinopathy therapies. Chin J Integr Med. 28:2018.
|
27
|
Wang Q, Zheng XL, Yang L, Shi F, Gao LB,
Zhong YJ, Sun H, He F, Lin Y and Wang X: Reactive oxygen
species-mediated apoptosis contributes to chemosensitization effect
of saikosaponins on cisplatin-induced cytotoxicity in cancer cells.
J Exp Clin Cancer Res. 29:1592010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Qian L, Murakami T, Kimura Y, Takahashi M
and Okita K: Saikosaponin A-induced cell death of a human hepatoma
cell line (HuH-7): The significance of the ‘sub-G1 peak’ in a DNA
histogram. Pathol Int. 45:207–214. 1995. View Article : Google Scholar : PubMed/NCBI
|
29
|
Cheng JT and Tsai CL: Anti-inflammatory
effect of saikogenin A. Biochem Pharmacol. 35:2483–2487. 1986.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Wang BF, Dai ZJ, Wang XJ, Bai MH, Lin S,
Ma HB, Wang YL, Song LQ, Ma XL, Zan Y, et al: Saikosaponin-d
increases the radiosensitivity of smmc-7721 hepatocellular
carcinoma cells by adjusting the g0/g1 and g2/m checkpoints of the
cell cycle. BMC Complement Altern Med. 13:2632013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Li M, Li Y, Sun L, Song JL and Lv C: High
mobility group box 1 promotes apoptosis of astrocytes after oxygen
glucose deprivation/reoxygenation by regulating the expression of
Bcl-2 and Bax. Beijing Da Xue Xue Bao Yi Xue Ban. 50:785–791.
2018.(In Chinese). PubMed/NCBI
|
32
|
Friedman MA and Carter SK: The therapy of
osteogenic sarcoma: Current status and thoughts for the future. J
Surg Oncol. 4:482–510. 1972. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kastan MB, Onyekwere O, Sidransky D,
Vogelstein B and Craig RW: Participation of p53 protein in the
cellular response to DNA damage. Cancer Res. 51:6304–6311.
1991.PubMed/NCBI
|
34
|
Edlich F: BCL-2 proteins and apoptosis:
Recent insights and unknowns. Biochem Biophys Res Commun.
500:26–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
35
|
Kanthan R, Radhi JM and Kanthan SC:
Gallbladder carcinomas: An immunoprognostic evaluation of P53,
Bcl-2, CEA and alpha-fetoprotein. Can J Gastroenterol. 14:181–184.
2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wang YW, Zhang K, Zhao S, Lv Y, Zhu J, Liu
H, Feng J, Liang W, Ma R and Wang J: HPV status and its correlation
with BCL2, p21, p53, Rb, and survivin expression in breast cancer
in a Chinese population. Biomed Res Int. 2017:63153922017.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Gumz ML, Zou H, Kreinest PA, Childs AC,
Belmonte LS, LeGrand SN, Wu KJ, Luxon BA, Sinha M, Parker AS, et
al: Secreted frizzled-related protein 1 loss contributes to tumor
phenotype of clear cell renal cell carcinoma. Clin Cancer Res.
13:4740–4748. 2007. View Article : Google Scholar : PubMed/NCBI
|